Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Cell to Cure ApS
APS
Active
Reklamebeskyttelse
CVR 39401975
Kajerødgård 9, 3460
Birkerød
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
14 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cell to Cure ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (4)
MR
Martin Roland Jensen
Management
Management
2022
MH
Mandana Haack-Sørensen
Management
Management
2018
JK
Jens Kastrup
Chief Executive Officer
Chief Executive Officer
2018
AE
Annette Ekblond
Management
Management
2018
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (1)
AØ
Anders Østergaard
Chairman
Chairman
2024
Former (1)
JK
Jesper Kihl
Board of Directors
Board of Directors
2022 – 2024
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Endeavour Cells ApS
Company
50–66.65%
50–66.65%
2024
JKastrup.ApS
Company
10–14.99%
10–14.99%
2024
Ekblond.ApS
Company
10–14.99%
10–14.99%
2024
LMN.ApS
Company
10–14.99%
10–14.99%
2024
MEDIC ADVICE ApS
Company
5–9.99%
5–9.99%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Cell to Cure ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
